224 related articles for article (PubMed ID: 27848050)
1. Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? Five-Year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial: Assessment and Incidence of True Lymphedema.
Wetzig N; Gill PG; Espinoza D; Mister R; Stockler MR; Gebski VJ; Ung OA; Campbell I; Simes J
Ann Surg Oncol; 2017 Apr; 24(4):1064-1070. PubMed ID: 27848050
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node based management or routine axillary clearance? Three-year outcomes of the RACS sentinel node biopsy versus axillary clearance (SNAC) 1 trial.
Wetzig N; Gill PG; Zannino D; Stockler MR; Gebski V; Ung O; Campbell I; Simes RJ
Ann Surg Oncol; 2015 Jan; 22(1):17-23. PubMed ID: 25316485
[TBL] [Abstract][Full Text] [Related]
3. Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial.
Gill G;
Ann Surg Oncol; 2009 Feb; 16(2):266-75. PubMed ID: 19050973
[TBL] [Abstract][Full Text] [Related]
4. Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial).
Smith MJ; Gill PG; Wetzig N; Sourjina T; Gebski V; Ung O; Campbell I; Kollias J; Coskinas X; Macphee A; Young L; Simes RJ; Stockler MR;
Breast Cancer Res Treat; 2009 Sep; 117(1):99-109. PubMed ID: 18925434
[TBL] [Abstract][Full Text] [Related]
5. 10-Year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection.
Campbell I; Wetzig N; Ung O; Espinoza D; Farshid G; Collins J; Kollias J; Gebski V; Mister R; Simes RJ; Stockler MR; Gill G
Breast; 2023 Aug; 70():70-75. PubMed ID: 37393644
[TBL] [Abstract][Full Text] [Related]
6. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
7. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
8. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
Mansel RE; Fallowfield L; Kissin M; Goyal A; Newcombe RG; Dixon JM; Yiangou C; Horgan K; Bundred N; Monypenny I; England D; Sibbering M; Abdullah TI; Barr L; Chetty U; Sinnett DH; Fleissig A; Clarke D; Ell PJ
J Natl Cancer Inst; 2006 May; 98(9):599-609. PubMed ID: 16670385
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
10. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.
McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708
[TBL] [Abstract][Full Text] [Related]
12. [Comparative analysis of the correlation between axillary treatment and upper limb lymphedema].
Lin Y; Xu Y; Zhang XH; Wang CJ; Sun Q
Zhonghua Wai Ke Za Zhi; 2019 Sep; 57(9):713-716. PubMed ID: 31474063
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection.
Golshan M; Martin WJ; Dowlatshahi K
Am Surg; 2003 Mar; 69(3):209-11; discussion 212. PubMed ID: 12678476
[TBL] [Abstract][Full Text] [Related]
14. Self-perceived, but not objective lymphoedema is associated with decreased long-term health-related quality of life after breast cancer surgery.
Sackey H; Johansson H; Sandelin K; Liljegren G; MacLean G; Frisell J; Brandberg Y
Eur J Surg Oncol; 2015 Apr; 41(4):577-84. PubMed ID: 25659877
[TBL] [Abstract][Full Text] [Related]
15. Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer.
Silberman AW; McVay C; Cohen JS; Altura JF; Brackert S; Sarna GP; Palmer D; Ko A; Memsic L
Ann Surg; 2004 Jul; 240(1):1-6. PubMed ID: 15213610
[TBL] [Abstract][Full Text] [Related]
16. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
[TBL] [Abstract][Full Text] [Related]
17. Arm lymphoedema and upper limb impairments in sentinel node-negative breast cancer patients: A one year follow-up study.
De Groef A; Van Kampen M; Tieto E; Schönweger P; Christiaens MR; Neven P; Geraerts I; Gebruers N; Devoogdt N
Breast; 2016 Oct; 29():102-8. PubMed ID: 27479040
[TBL] [Abstract][Full Text] [Related]
18. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
Rebegea L; Firescu D; Dumitru M; Anghel R
Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
[TBL] [Abstract][Full Text] [Related]
19. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
[TBL] [Abstract][Full Text] [Related]
20. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance.
Leidenius M; Leivonen M; Vironen J; von Smitten K
J Surg Oncol; 2005 Oct; 92(1):23-31. PubMed ID: 16180231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
